Form 4: Glaukos Corp Executive Navratil Sells Shares to Cover Tax Obligations

Glaukos Corporation's Chief Development Officer, Tomas Navratil, sold 1,185 shares to cover tax obligations related to vesting restricted stock units.

Summary

• Tomas Navratil, Chief Development Officer at Glaukos Corporation, sold 1,185 shares of common stock on January 6, 2025.
• The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units previously granted on January 4, 2021.
• The shares were sold at a price of $149.68 per share.
• Following the transaction, Navratil beneficially owns 75,853 shares, which includes 45,972 unvested restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no significant positive or negative implications.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• The sale of shares to cover tax obligations upon vesting of restricted stock units is a standard practice across publicly listed companies.
• Many companies use similar equity compensation plans for their executives, and these transactions are regularly reported via SEC Form 4 filings.
• Comparable companies in the medical device industry also have executives who regularly report similar transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive to cover tax obligations.

Key Dates

Keywords

Glaukos Corp, insider trading, Form 4, stock sale, restricted stock units, tax obligations, executive compensation, equity securities